vs
博士伦（BLCO）与TopBuild Corp（BLD）财务数据对比。点击上方公司名可切换其他公司
TopBuild Corp的季度营收约是博士伦的1.1倍（$1.5B vs $1.4B），TopBuild Corp净利率更高（7.0% vs -4.1%，领先11.2%），TopBuild Corp同比增速更快（13.2% vs 9.8%），TopBuild Corp自由现金流更多（$159.4M vs $60.0M），过去两年博士伦的营收复合增速更高（13.1% vs 7.8%）
博士伦是知名眼健康产品企业，总部位于加拿大安大略省沃恩市，是全球规模最大的隐形眼镜、镜片护理产品、眼科药品、人工晶体及其他眼科手术产品供应商之一。品牌1853年由验光师约翰·鲍什与合伙人亨利·朗姆在美国纽约罗切斯特创立，曾是美国历史最悠久的持续运营企业之一，2013年被整体收购。
HashiCorp是总部位于美国加利福尼亚州旧金山的软件企业，2012年由米切尔·桥本与阿蒙·达德加创立，采用免费增值商业模式，为开发、运维及安全从业人员提供云基础设施配置、防护、运行与连接相关的工具及产品。
BLCO vs BLD — 直观对比
营收规模更大
BLD
是对方的1.1倍
$1.4B
营收增速更快
BLD
高出3.4%
9.8%
净利率更高
BLD
高出11.2%
-4.1%
自由现金流更多
BLD
多$99.4M
$60.0M
两年增速更快
BLCO
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.5B |
| 净利润 | $-58.0M | $104.5M |
| 毛利率 | — | 27.2% |
| 营业利润率 | 8.0% | 12.1% |
| 净利率 | -4.1% | 7.0% |
| 营收同比 | 9.8% | 13.2% |
| 净利润同比 | -1833.3% | -30.6% |
| 每股收益（稀释后） | $-0.16 | $3.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLCOBLD
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | $1.2B | $1.4B | ||
| Q1 24 | $1.1B | $1.3B |
净利润BLCOBLD
| Q4 25 | $-58.0M | $104.5M | ||
| Q3 25 | $-28.0M | $142.2M | ||
| Q2 25 | $-62.0M | $151.6M | ||
| Q1 25 | $-212.0M | $123.4M | ||
| Q4 24 | $-3.0M | $150.5M | ||
| Q3 24 | $4.0M | $169.0M | ||
| Q2 24 | $-151.0M | $150.7M | ||
| Q1 24 | $-167.0M | $152.4M |
毛利率BLCOBLD
| Q4 25 | — | 27.2% | ||
| Q3 25 | — | 30.1% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 28.5% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | — | 31.0% | ||
| Q1 24 | — | 30.3% |
营业利润率BLCOBLD
| Q4 25 | 8.0% | 12.1% | ||
| Q3 25 | 7.4% | 15.4% | ||
| Q2 25 | -0.9% | 16.9% | ||
| Q1 25 | -7.3% | 14.4% | ||
| Q4 24 | 6.8% | 16.6% | ||
| Q3 24 | 3.6% | 17.8% | ||
| Q2 24 | 2.1% | 15.4% | ||
| Q1 24 | 0.5% | 16.8% |
净利率BLCOBLD
| Q4 25 | -4.1% | 7.0% | ||
| Q3 25 | -2.2% | 10.2% | ||
| Q2 25 | -4.9% | 11.7% | ||
| Q1 25 | -18.6% | 10.0% | ||
| Q4 24 | -0.2% | 11.5% | ||
| Q3 24 | 0.3% | 12.3% | ||
| Q2 24 | -12.4% | 11.0% | ||
| Q1 24 | -15.2% | 11.9% |
每股收益（稀释后）BLCOBLD
| Q4 25 | $-0.16 | $3.69 | ||
| Q3 25 | $-0.08 | $5.04 | ||
| Q2 25 | $-0.18 | $5.32 | ||
| Q1 25 | $-0.60 | $4.23 | ||
| Q4 24 | $-0.00 | $5.07 | ||
| Q3 24 | $0.01 | $5.65 | ||
| Q2 24 | $-0.43 | $4.78 | ||
| Q1 24 | $-0.48 | $4.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.0M | $184.7M |
| 总债务越低越好 | $5.0B | $2.8B |
| 股东权益账面价值 | $6.4B | $2.3B |
| 总资产 | $14.0B | $6.6B |
| 负债/权益比越低杠杆越低 | 0.78× | 1.23× |
8季度趋势，按日历期对齐
现金及短期投资BLCOBLD
| Q4 25 | $383.0M | $184.7M | ||
| Q3 25 | $310.0M | $1.1B | ||
| Q2 25 | $266.0M | $842.5M | ||
| Q1 25 | $202.0M | $308.8M | ||
| Q4 24 | $305.0M | $400.3M | ||
| Q3 24 | $329.0M | $257.3M | ||
| Q2 24 | $285.0M | $463.2M | ||
| Q1 24 | $315.0M | $968.8M |
总债务BLCOBLD
| Q4 25 | $5.0B | $2.8B | ||
| Q3 25 | $5.0B | $2.9B | ||
| Q2 25 | $5.0B | $1.9B | ||
| Q1 25 | $4.8B | $1.4B | ||
| Q4 24 | $4.8B | $1.4B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | $4.6B | $1.4B | ||
| Q1 24 | $4.6B | $1.4B |
股东权益BLCOBLD
| Q4 25 | $6.4B | $2.3B | ||
| Q3 25 | $6.4B | $2.2B | ||
| Q2 25 | $6.4B | $2.1B | ||
| Q1 25 | $6.4B | $2.1B | ||
| Q4 24 | $6.5B | $2.2B | ||
| Q3 24 | $6.6B | $2.1B | ||
| Q2 24 | $6.5B | $2.4B | ||
| Q1 24 | $6.7B | $2.7B |
总资产BLCOBLD
| Q4 25 | $14.0B | $6.6B | ||
| Q3 25 | $13.8B | $6.4B | ||
| Q2 25 | $13.8B | $5.1B | ||
| Q1 25 | $13.4B | $4.6B | ||
| Q4 24 | $13.5B | $4.7B | ||
| Q3 24 | $13.5B | $4.7B | ||
| Q2 24 | $13.3B | $4.9B | ||
| Q1 24 | $13.3B | $5.3B |
负债/权益比BLCOBLD
| Q4 25 | 0.78× | 1.23× | ||
| Q3 25 | 0.77× | 1.29× | ||
| Q2 25 | 0.77× | 0.88× | ||
| Q1 25 | 0.76× | 0.65× | ||
| Q4 24 | 0.74× | 0.62× | ||
| Q3 24 | 0.70× | 0.66× | ||
| Q2 24 | 0.71× | 0.59× | ||
| Q1 24 | 0.69× | 0.52× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $136.0M | $176.7M |
| 自由现金流经营现金流 - 资本支出 | $60.0M | $159.4M |
| 自由现金流率自由现金流/营收 | 4.3% | 10.7% |
| 资本支出强度资本支出/营收 | 5.4% | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.69× |
| 过去12个月自由现金流最近4个季度 | $-66.0M | $696.9M |
8季度趋势，按日历期对齐
经营现金流BLCOBLD
| Q4 25 | $136.0M | $176.7M | ||
| Q3 25 | $137.0M | $233.3M | ||
| Q2 25 | $35.0M | $193.7M | ||
| Q1 25 | $-25.0M | $152.6M | ||
| Q4 24 | $22.0M | $266.2M | ||
| Q3 24 | $154.0M | $240.7M | ||
| Q2 24 | $15.0M | $90.4M | ||
| Q1 24 | $41.0M | $178.8M |
自由现金流BLCOBLD
| Q4 25 | $60.0M | $159.4M | ||
| Q3 25 | $63.0M | $216.2M | ||
| Q2 25 | $-54.0M | $182.2M | ||
| Q1 25 | $-135.0M | $139.2M | ||
| Q4 24 | $-70.0M | $253.7M | ||
| Q3 24 | $94.0M | $219.8M | ||
| Q2 24 | $-57.0M | $74.3M | ||
| Q1 24 | $-26.0M | $158.9M |
自由现金流率BLCOBLD
| Q4 25 | 4.3% | 10.7% | ||
| Q3 25 | 4.9% | 15.5% | ||
| Q2 25 | -4.2% | 14.0% | ||
| Q1 25 | -11.9% | 11.3% | ||
| Q4 24 | -5.5% | 19.3% | ||
| Q3 24 | 7.9% | 16.0% | ||
| Q2 24 | -4.7% | 5.4% | ||
| Q1 24 | -2.4% | 12.4% |
资本支出强度BLCOBLD
| Q4 25 | 5.4% | 1.2% | ||
| Q3 25 | 5.8% | 1.2% | ||
| Q2 25 | 7.0% | 0.9% | ||
| Q1 25 | 9.7% | 1.1% | ||
| Q4 24 | 7.2% | 1.0% | ||
| Q3 24 | 5.0% | 1.5% | ||
| Q2 24 | 5.9% | 1.2% | ||
| Q1 24 | 6.1% | 1.6% |
现金转化率BLCOBLD
| Q4 25 | — | 1.69× | ||
| Q3 25 | — | 1.64× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 1.77× | ||
| Q3 24 | 38.50× | 1.42× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 1.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLCO
| Overthe Counter Products | $489.0M | 35% |
| Pharmaceuticals | $378.0M | 27% |
| Other | $263.0M | 19% |
| Surgical | $249.0M | 18% |
| Brandedand Other Generic Products | $14.0M | 1% |
| Other Revenues | $3.0M | 0% |
| Pharmaceutical Products | $2.0M | 0% |
BLD
| Distribution Segment | $755.4M | 51% |
| Residential | $557.9M | 38% |
| All Other Products | $91.9M | 6% |
| Glass And Windows | $51.5M | 3% |
| Rain Gutters | $27.1M | 2% |
